Michael Terrence Gibbs, General Counsel at T2 Biosystems, Inc. (TTOO), sold 239 shares at $0.48 ($115) on 2023-03-28, disclosed to the SEC on 2023-04-06.
Scheduled sale ($115) by General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TTOO | SELL | 2021-03-25 | $14K | — | Filing → |
| TTOO | SELL | 2021-02-23 | $15K | — | Filing → |
| TTOO | SELL | 2020-02-25 | $5K | — | Filing → |